ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.33
-0.21 (-2.46%)
Jun 29, 2026, 2:11 PM EDT - Market open
ARS Pharmaceuticals Employees
As of March 31, 2026, ARS Pharmaceuticals had 159 total employees, including 154 full-time and 5 part-time employees. The number of employees decreased by 4 or -2.45% since the number was last reported on December 31, 2025.
Employees
159
Change
-4
Growth
-2.45%
Revenue / Employee
$622,553
Profits / Employee
-$1,245,132
Market Cap
827.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| Geron | 258 |
| Janux Therapeutics | 108 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Vor Biopharma | 76 |
| Zevra Therapeutics | 61 |
SPRY News
- 4 days ago - ARS reports no new commercial formulary additions, coverage decisions for neffy - TheFly
- 4 days ago - ARS Pharmaceuticals Provides Commercial and Financial Updates - GlobeNewsWire
- 4 weeks ago - ARS Pharmaceuticals price target raised to $30 from $12 at Cantor Fitzgerald - TheFly
- 6 weeks ago - ARS Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - ARS Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 weeks ago - ARS Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - ARS Pharmaceuticals reports Q1 EPS (61c), consensus (54c) - TheFly
- 6 weeks ago - ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire